Screener
ANI Pharmaceuticals ANIP Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TaxesPayableCurrent.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's income taxes payable?
- ANI Pharmaceuticals (ANIP) reported income taxes payable of $3.53M in Q2 2026.
- How has ANI Pharmaceuticals's income taxes payable changed year-over-year?
- ANI Pharmaceuticals's income taxes payable increased by 7.2% year-over-year, from $3.29M to $3.53M.
- What is the long-term trend for ANI Pharmaceuticals's income taxes payable?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's income taxes payable has grown at a -10.5% compound annual growth rate (CAGR), from $3.91M to $2.24M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about ANI Pharmaceuticals's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude